Ferumoxytol Injection Iron Replacement 510 mg Single-Dose Vial 17 mL (RX)


Ferumoxytol Injection by Sandoz is a high-potency intravenous iron replacement medication, supplied as a 30 mg/mL solution in a convenient 17 mL single-dose vial. Designed for healthcare professionals, Ferumoxytol provides rapid and effective treatment of iron deficiency anemia (IDA), particularly in adult patients with chronic kidney disease (CKD) or when oral iron therapy is ineffective or not tolerated.
Ferumoxytol Injection is indicated for:
Standard Adult Dosage:
Ferumoxytol consists of a superparamagnetic iron oxide core surrounded by a carbohydrate shell, allowing for controlled release of iron into the body. The released iron is rapidly incorporated into hemoglobin and other essential iron-dependent proteins, quickly correcting iron deficiency and enabling efficient erythropoiesis (red blood cell production).
The most common adverse reactions include:
Serious Side Effects:
Ferumoxytol Injection by Sandoz offers a safe, efficient, and reliable solution for rapid iron repletion in adults with chronic kidney disease or those who cannot tolerate oral iron, helping to restore energy, reduce anemia symptoms, and improve quality of life under proper medical supervision.
For complete prescribing information, always refer to the official product monograph or consult your healthcare provider.
Ferumoxytol Injection by Sandoz is a high-potency intravenous iron replacement medication, supplied as a 30 mg/mL solution in a convenient 17 mL single-dose vial. Designed for healthcare professionals, Ferumoxytol provides rapid and effective treatment of iron deficiency anemia (IDA), particularly in adult patients with chronic kidney disease (CKD) or when oral iron therapy is ineffective or not tolerated.
Ferumoxytol Injection is indicated for:
Standard Adult Dosage:
Ferumoxytol consists of a superparamagnetic iron oxide core surrounded by a carbohydrate shell, allowing for controlled release of iron into the body. The released iron is rapidly incorporated into hemoglobin and other essential iron-dependent proteins, quickly correcting iron deficiency and enabling efficient erythropoiesis (red blood cell production).
The most common adverse reactions include:
Serious Side Effects:
Ferumoxytol Injection by Sandoz offers a safe, efficient, and reliable solution for rapid iron repletion in adults with chronic kidney disease or those who cannot tolerate oral iron, helping to restore energy, reduce anemia symptoms, and improve quality of life under proper medical supervision.
For complete prescribing information, always refer to the official product monograph or consult your healthcare provider.
Ferumoxytol is an intravenous (IV) iron replacement therapy used to treat iron deficiency anemia (IDA) in adults with chronic kidney disease (CKD) and, in some cases, for other patients unable to tolerate oral iron or for whom oral iron is ineffective.
It is given as a slow intravenous infusion or injection by a healthcare professional, usually in a clinic or hospital setting. The recommended dosing is two injections at least 3 to 8 days apart.
Improvement in hemoglobin levels is often seen within 1 to 4 weeks after completing the treatment course, depending on individual patient response.
Common side effects include dizziness, nausea, headache, swelling, diarrhea, low blood pressure, and reactions at the injection site. Serious but rare side effects include allergic or hypersensitivity reactions.
Yes, rare but potentially serious risks include severe allergic reactions (anaphylaxis) and hypotension during or after the injection. The infusion should be done in a setting where emergency care is available.
It should not be used in patients with a known hypersensitivity to ferumoxytol or any of its components, or who have experienced a serious allergic reaction to any IV iron product.
The safety of ferumoxytol during pregnancy or breastfeeding is not fully established. Tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding before receiving this medication.
Yes. Ferumoxytol can affect the quality of MRI images for up to 3 months after administration. Let your healthcare team and radiologist know if you received this drug before having an MRI.
Ferumoxytol can be administered relatively quickly and often requires fewer infusions for a full dose compared to other IV iron formulations.
Notify your healthcare provider immediately, as these could be signs of a serious allergic reaction requiring prompt treatment.
Usually, you do not need to stop medications, but always discuss your full medication list—including over-the-counter drugs and supplements—with your provider.
Currently, ferumoxytol is approved for use in adults; its safety and effectiveness in children have not been established.
Ferumoxytol vials should be stored at controlled room temperature and protected from light until prepared for injection by a healthcare professional.
Yes. Blood tests to check iron levels, hemoglobin, and kidney function are usually required before and after treatment to monitor response and safety.
Ferumoxytol should not be mixed with or infused simultaneously with other medications through the same IV line. A separate line or thorough flushing is recommended.
You need an account to add products to your wishlist. Log in or create an account to start saving your favorites.